Capgemini is highlighting the role of artificial intelligence in transforming pharmaceutical drug discovery. The company is discussing how ai and digitalization can improve the early stages of drug development and make biopharma research and development more responsible and patient-centric. The potential of ai to transform the pharmaceutical industry is also being noted by other outlets, with some discussing its potential impact on healthcare and biopharma research.